Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rhinophototherapy vs Intranasal Corticosteroids in Allergic Rhinitis
NCT05919316Completed
- Sponsor
- Universiti Kebangsaan Malaysia
- Start
- Jul 2023
- Primary completion
- Oct 2024
- Countries
- 1
01
Overview
Randomised, single-blind trial in allergic rhinitis (AR) (2 arms), sponsored by Universiti Kebangsaan Malaysia. Primary endpoints: Symptoms Score of Allergic Rhinitis at 2 weeks, Peak Nasal Inspiratory Flow at 2 weeks and 3 more. Started Jul 2023; status: completed.
02
Conditions
allergic rhinitis (AR)
Beyond the preview
Go deeper on NCT05919316.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05919316.